Sunayama et al. reported that FoxO3a knockdown reduced the expression of differentiation markers in patient-derived GBM-SCs and that constitutively active FoxO3a induced GBM-SC differentiation [43]. This evidence concerns the gene FOXO3 and glioblastoma.